Cidophage Retard 850 Mg 30 Tablets

Cidophage Retard 850 Mg 30 Tablets

Description:

Cidophage Retard 850 mg is an oral antidiabetic prescription medicine containing metformin hydrochloride, a biguanide used for the management of type 2 diabetes mellitus. It is formulated as prolonged‑release (retard) film‑coated tablets to provide a gradual release of metformin over time, helping to control blood glucose levels throughout the day with fewer daily doses. Cidophage Retard 850 mg is typically used as an adjunct to diet and exercise and may be used alone or in combination with other antidiabetic medications as directed by a physician. It is part of comprehensive diabetes care to help reduce the risk of diabetes‑related complications when used consistently and correctly.

Indications:

• Management of type 2 diabetes mellitus (non‑insulin‑dependent diabetes mellitus) in adults, particularly in overweight patients, when dietary measures and physical exercise alone are insufficient to achieve adequate glycemic control.
• May be used as monotherapy or in combination with other oral antidiabetic agents or insulin as prescribed by a healthcare professional.
• Helps reduce elevated fasting and postprandial blood glucose levels.
• Supports long‑term control of blood sugar to help reduce the risk of diabetes complications such as neuropathy, nephropathy, retinopathy, and cardiovascular disease when combined with appropriate lifestyle measures.

Active Ingredients / Key Components:

• Metformin hydrochloride – 850 mg per prolonged‑release (retard) film‑coated tablet.
• Other tablet excipients (such as fillers, binders, coating agents, and stabilizers) are present but detailed composition is not available in the provided information.

Dosage & Administration / How to Use:

• Cidophage Retard 850 mg should always be used exactly as prescribed by your doctor. Do not change your dose without medical advice.
• General adult dosing for metformin (immediate‑release) typically starts at 250 mg twice or three times daily with meals and is increased gradually every 2 weeks up to a maximum of 3 g daily. However, this product is a prolonged‑release 850 mg tablet, and the exact regimen (e.g., once daily in the evening or divided doses) must be determined by the treating physician.
• Tablets should be swallowed whole with a glass of water. Do not crush, chew, or split the prolonged‑release tablets, as this may alter the release profile and increase the risk of side effects.
• It is usually recommended to take the tablet with or after food to reduce gastrointestinal side effects such as nausea or stomach upset.
• If a dose is missed, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed tablet.
• Use in children: The provided information indicates that metformin dosage here is not applicable for children. Cidophage Retard 850 mg is generally intended for adults; pediatric use should only occur if specifically prescribed by a specialist.
• Duration of treatment is long term in most patients with type 2 diabetes and should not be stopped abruptly without consulting your doctor.

Clinical Benefits:

• Helps lower elevated blood glucose levels by suppressing hepatic gluconeogenesis (reducing glucose production in the liver).
• Enhances insulin‑mediated glucose uptake and utilization in muscle and adipose tissue, improving insulin sensitivity.
• Promotes peripheral glucose utilization by increasing anaerobic glycolysis and enhancing GLUT1 (glucose transporter‑1) translocation to the cell membrane.
• Reduces intestinal absorption of glucose and other hexose sugars, contributing to improved glycemic control.
• May improve lipid profile in type 2 diabetic patients, helping to lower total cholesterol and triglycerides and support cardiovascular health.
• Prolonged‑release (retard) formulation provides more stable plasma levels of metformin, which may improve tolerability and convenience with fewer daily doses.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to metformin hydrochloride or any component of the formulation.
• Contraindicated in patients with severe renal impairment or significant reduction in kidney function, due to increased risk of lactic acidosis.
• Contraindicated in acute conditions that may alter renal function such as dehydration, severe infection, shock, or intravascular administration of iodinated contrast agents (metformin may need to be temporarily discontinued before and after such procedures as directed by your doctor).
• Use with caution in patients with hepatic impairment, heart failure, respiratory failure, or conditions associated with hypoxia, as these increase the risk of lactic acidosis.
• Avoid excessive alcohol intake during treatment, as alcohol increases the risk of lactic acidosis and may affect blood glucose control.
• Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding. Your doctor will decide whether to continue metformin or switch to insulin or another therapy.
• Inform your doctor about all other medications you are taking, including insulin, other oral antidiabetics, diuretics, corticosteroids, beta‑blockers, and contrast media, to avoid interactions and dose adjustments.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision; it is a prescription medicine for confirmed diabetes management.
• Keep out of reach of children.
• If you develop symptoms such as unexplained muscle pain, severe weakness, abdominal discomfort, rapid breathing, or feeling very unwell, seek immediate medical attention as these may be signs of lactic acidosis, a rare but serious side effect.

Side Effects:

• Common side effects: Gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, diarrhea, loss of appetite, and metallic taste in the mouth, especially at the start of therapy. These often improve as treatment continues or with dose adjustment.
• Less common side effects: Headache, dizziness, mild skin reactions (rash, itching), and weakness.
• Long‑term use may be associated with decreased absorption of vitamin b12, which can rarely lead to vitamin b12 deficiency; your doctor may monitor levels if treatment is prolonged.
• Serious but rare side effect: Lactic acidosis, characterized by rapid breathing, severe fatigue, muscle pain, abdominal pain, feeling cold, slow or irregular heartbeat, or drowsiness. This is a medical emergency and requires immediate discontinuation and urgent medical care.
• If you experience any severe, persistent, or unusual symptoms, or signs of very low blood sugar when used with other antidiabetics (sweating, tremor, confusion, palpitations), contact your doctor promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: Prolonged‑release (retard) film‑coated tablets.
• Strength: 850 mg metformin hydrochloride per tablet.
• Count: 30 tablets per pack.
• Intended use: Prescription oral antidiabetic medicine for adults with type 2 diabetes.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.